Infant Bacterial Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:9IB Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
14 Nov 24	Buy€1,469	Maria Ekdahl	Individual	500	€2.94
02 Sep 24	Buy€30,845	Anthon Jahreskog	Individual	14,000	€2.20
02 Sep 24	Buy€2,247	Maria Ekdahl	Individual	1,000	€2.25
28 May 24	Buy€1,303	Maria Ekdahl	Individual	156	€8.37
17 May 24	Buy€2,251	Anthon Jahreskog	Individual	270	€8.38

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9IB?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	522,225	3.88%
Private Companies	1,873,433	13.9%
General Public	2,118,877	15.7%
Institutions	8,956,885	66.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 84.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.3%	SIX Group AG, Asset Management Arm	1,515,579	€7.9m	2.37%	1.64%
11.1%	Northern Trust Global Investments	1,497,162	€7.8m	33.5%	no data
9.98%	Fourth Swedish National Pension Fund (AP4)	1,344,000	€7.0m	0%	0.03%
8.72%	Annwall & Rothschild Investments AB	1,174,634	€6.1m	0%	no data
5.19%	Lochnest Pty Ltd	698,799	€3.6m	0%	no data
4.94%	Keel Capital AB	666,053	€3.5m	0%	29.66%
4.6%	Premier Fund Managers Ltd.	619,991	€3.2m	0%	0.04%
4.47%	AMF Fonder AB	601,902	€3.1m	0%	0.01%
3.29%	SEB Investment Management AB	443,250	€2.3m	0%	no data
3.24%	Ålandsbanken Asset Management Ab	436,172	€2.3m	6.62%	5.12%
2.76%	Avanza Fonder AB	372,309	€1.9m	98.3%	0.02%
2.76%	Tredje AP-fonden	371,774	€1.9m	0%	0.01%
2.75%	David Dangoor	370,455	€1.9m	0.75%	no data
2.55%	IBG LLC, Asset Management Arm	343,432	€1.8m	0%	0.58%
2.31%	Pictet Asset Management Limited	311,169	€1.6m	23.2%	no data
1.81%	Nordnet AB (publ), Asset Management Arm	243,315	€1.3m	16%	0.18%
0.79%	Staffan Stromberg	106,910	€554.3k	0%	no data
0.57%	Handelsbanken Asset Management	76,687	€397.6k	0%	no data
0.35%	FCG Fonder AB	46,603	€241.6k	0%	0.03%
0.3%	Schroder Investment Management Limited	40,000	€207.4k	0%	no data
0.18%	Anthon Jahreskog	24,270	€125.8k	0%	no data
0.088%	Marathon Asset Management Limited	11,850	€61.4k	-68.3%	no data
0.083%	Anders Kronström	11,194	€58.0k	0%	no data
0.063%	Skandia Fonder AB	8,432	€43.7k	0%	no data
0.043%	Storebrand Fonder AB,	5,848	€30.3k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/14 05:58
End of Day Share Price	2025/03/31 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Infant Bacterial Therapeutics AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.